What is the management approach for bronchomalacia post lung transplant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bronchomalacia Post Lung Transplant

Bronchomalacia following lung transplantation requires a multispecialty approach with interventions ranging from noninvasive positive pressure ventilation to endobronchial stenting depending on severity and impact on respiratory function. 1

Diagnosis and Identification

  • Bronchomalacia should be considered in the differential diagnosis of delayed post-transplant lung function decline, particularly when patients present with symptoms of airway obstruction 2
  • Bronchomalacia can occur in both the allograft airway and native airway (in single lung transplant recipients) 2
  • Diagnosis is confirmed via bronchoscopic evaluation, which reveals excessive airway collapse during expiration 1

Management Approach

Conservative Management

  • For mild cases or when bronchomalacia is associated with acute rejection, appropriate medical therapy for the underlying rejection may resolve the condition 3
  • Noninvasive positive pressure ventilation can provide external support to prevent airway collapse in selected cases 1
  • Aggressive management of respiratory infections is essential as infections can worsen airway complications 4

Interventional Bronchoscopic Procedures

  • For persistent focal bronchomalacia that causes significant symptoms or decline in pulmonary function, endobronchial stent placement is the primary intervention 5
  • Types of stents used include:
    • Balloon-expandable metallic (Palmaz) stents 3
    • Self-expanding metallic stents 5
  • Stent placement procedure:
    • Can be performed under conscious sedation using a flexible bronchoscope 3
    • Should target the specific area of malacia to restore airway patency 5

Outcomes of Stent Placement

  • Significant improvement in FEV1 has been documented at 3 months (1.45 ± 0.50 L), 6 months (1.59 ± 0.57 L), and 12 months (1.59 ± 0.53 L) post-stent placement compared to baseline (1.29 ± 0.43 L) 5
  • Reduction in pulmonary infection rates from 6.97/100 days ± 6.33 to 5.74/100 days ± 7.76 following stent placement 5

Potential Complications of Stent Placement

  • Partial dehiscence of the stent from the bronchial wall 3
  • Stent migration 3
  • Partial obstruction of segmental bronchial orifices by stents placed in the main bronchus 3
  • Longitudinal stent collapse 3
  • Recurrent stenosis (reported in 17.3% of cases) 5

Monitoring and Follow-up

  • Regular bronchoscopic surveillance to assess stent position and function 5
  • Spirometric evaluation at 3-month intervals to monitor lung function 5
  • Vigilant monitoring for signs of respiratory infection 4, 5

Special Considerations

  • In cases where bronchomalacia is accompanied by bronchial stenosis, a combined approach may be necessary 3, 5
  • Some stents may need to be removed or replaced if complications develop 3
  • Stent removal can be performed using flexible bronchoscopy in some cases, while others may require rigid bronchoscopy in the operating room 3

Prevention

  • Early and aggressive medical management of rejection and infection may help prevent the development of bronchomalacia 1
  • Surgical techniques during transplantation may influence the risk of subsequent airway complications 1, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.